Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.tem.2021.06.004 http://scihub22266oqcxt.onion/10.1016/j.tem.2021.06.004 34275726!8226104!34275726     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Trends+Endocrinol+Metab 2021 ; 32 (9): 706-720 Nephropedia Template TP {{tp|p=34275726|t=2021. COVID-19 and obesity: fighting two pandemics with intermittent fasting |pdf=|usr=}}{{34275726}} gab.com Text COVID-19 and obesity: fighting two pandemics with intermittent fasting JO: Trends Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=34275726 #FOAvip Obesity is strongly and independently associated with an increased risk of severe illness and death from coronavirus disease 2019 (COVID-19). The pathophysiological changes that result from elevated body weight lead to metabolic dysfunction, chronic inflammation, impaired immunological responses, and multisystem disorders, which increase vulnerability to severe illness from COVID-19. While vaccination strategies are under way across the world, the second and third waves of the pandemic, along with the emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains, continue to threaten the stability of medical systems worldwide. Furthermore, evidence from previous pandemics suggests that vaccines are less effective in obese individuals than in their healthy-weight counterparts over the long term. Therefore, a consideration of lifestyle changes that can boost metabolic health and immunity is critical to reduce the risk of complications and severe illness from viral infection. In this review, we discuss the potential mechanisms linking excess body weight with COVID-19 morbidity. We also present evidence that intermittent fasting (IF), a dietary program that has gained popularity in recent years, may be an effective strategy to improve metabolic health and immunity and thus reduce the impact of obesity on COVID-19 morbidity and mortality. Twit Text FOAVip COVID-19 and obesity: fighting two pandemics with intermittent fasting ????Trends Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=34275726 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34275726 #FOAvip English Wikipedia <ref>{{Cite pmid|34275726}}</ref> COVID-19 and obesity: fighting two pandemics with intermittent fasting #MMPMID34275726 Ealey KN; Phillips J; Sung HK Trends Endocrinol Metab 2021[Sep]; 32 (9): 706-720 PMID34275726show ga Obesity is strongly and independently associated with an increased risk of severe illness and death from coronavirus disease 2019 (COVID-19). The pathophysiological changes that result from elevated body weight lead to metabolic dysfunction, chronic inflammation, impaired immunological responses, and multisystem disorders, which increase vulnerability to severe illness from COVID-19. While vaccination strategies are under way across the world, the second and third waves of the pandemic, along with the emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains, continue to threaten the stability of medical systems worldwide. Furthermore, evidence from previous pandemics suggests that vaccines are less effective in obese individuals than in their healthy-weight counterparts over the long term. Therefore, a consideration of lifestyle changes that can boost metabolic health and immunity is critical to reduce the risk of complications and severe illness from viral infection. In this review, we discuss the potential mechanisms linking excess body weight with COVID-19 morbidity. We also present evidence that intermittent fasting (IF), a dietary program that has gained popularity in recent years, may be an effective strategy to improve metabolic health and immunity and thus reduce the impact of obesity on COVID-19 morbidity and mortality. |*COVID-19/diet therapy/prevention & control[MESH] |*Fasting[MESH] |*Obesity/complications/diet therapy[MESH]COVID-19 and obesity: fighting two pandemics with intermittent fasting(epmc).pdf DeepDyve Pubget Overpricing